Health Condition 1: J454- Moderate persistent asthma
Conditions
Interventions
Intervention1: Unani Formulation: 12gms in the decoction form orally twice daily before meal for 45days.
Intervention2: Unani Formulation: 12gms in the decoction form orally twice daily before meal fo
Sponsors
National Institute of Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patient with symptoms of Wheeze, Cough with expectoration, Mild to moderate Paroxysmal Dyspnoea 2.Mild to moderate asthma 3.Patients who have consented for the study
Exclusion criteria
Exclusion criteria: 1.Patients below 18 and above 50 years of age 2.Acute or Severe Exacerbation(FEV1 or PEF 3.Patients with Systemic illnesses such as HTN, IHD, DM 4.Patients with a History of Allergic Rhinitis, COPD, Pneumonia, Occupational lung diseases,Pulmonary tuberculosis 5.Pregnant and lactating women 6.Patients who had received corticosteroids, Bronchodilators or CAM therapy within 2weeks prior to enrolment 7.Patients who have not consented for the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in FEV1, FEV1/FVC ratio, PEFTimepoint: 0th day and 45th day | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in ACT scoreTimepoint: 0th day, 15th day, 30th day and 45th day | — |
Countries
India
Contacts
Public ContactProf Mansoor Ahmad Siddiqui
National Institute of Unani Medicine
Outcome results
None listed